| 期 |
标题 |
文件 |
| 卷 30, 编号 8 (2024) |
2,5-Diketopiperazines (DKPs): Promising Scaffolds for Anticancer Agents |
(Eng)
|
|
Goher S., Abdrabo W., Veerakanellore G., Elgendy B.
|
| 卷 30, 编号 22 (2024) |
3′-Daidzein Sulfonate Sodium Protects against Glutamate-induced Neuronal Injuries by Regulating NMDA Receptors |
(Eng)
|
|
Feng R., Luo L., Han Z., Qi Y., Xiao H., Huang C., Peng W., Liu R., Huang Z.
|
| 卷 30, 编号 38 (2024) |
3D Printed Nanosensors for Cancer Diagnosis: Advances and Future Perspective |
(Eng)
|
|
Gupta B., Malviya R., Srivastava S., Ahmad I., Rab S., Singh D.
|
| 卷 30, 编号 23 (2024) |
A Complex Interplay between Nutrition and Alcohol use Disorder: Implications for Breaking the Vicious Cycle |
(Eng)
|
|
White B., Sirohi S.
|
| 卷 30, 编号 16 (2024) |
A Comprehensive Guide to the Development, Evaluation, and Future Prospects of Self-nanoemulsifying Drug Delivery Systems for Poorly Water-soluble Drugs |
(Eng)
|
|
Chauhan A., Kamal R., Mishra R., Shekho D., Awasthi A.
|
| 卷 30, 编号 1 (2024) |
A Mechanistic Review on Therapeutic Potential of Medicinal Plants and their Pharmacologically Active Molecules for Targeting Metabolic Syndrome |
(Eng)
|
|
Gauttam V., Munjal K., Chopra H., Ahmad A., Rana M., Kamal M.
|
| 卷 30, 编号 7 (2024) |
A New Cell Model Overexpressing sTGFBR3 for Studying Alzheimer's Disease In vitro |
(Eng)
|
|
Chen J., Zhou L., Zhao Q., Qi Z.
|
| 卷 30, 编号 38 (2024) |
A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived miRNAs |
(Eng)
|
|
Feng Y.
|
| 卷 30, 编号 32 (2024) |
A Quest for Potential Role of Vitamin D in Type II Diabetes Mellitus Induced Diabetic Kidney Disease |
(Eng)
|
|
Obaid A., Farrash W., Mujalli A., Singh S.
|
| 卷 30, 编号 32 (2024) |
A Rapid, Sensitive, and High-throughput Method for the Simultaneous Determination of Antihypertensive Drug Combinations in Dog Plasma by UHPLC-MS/MS: The Assessment of Predicable Bioequivalence of In-vitro Dissolution Condition |
(Eng)
|
|
Wang Y., Wang R., Wang H., Liu R., Bi K., Li Q.
|
| 卷 30, 编号 12 (2024) |
A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis |
(Eng)
|
|
Kumar B., Deshmukh R.
|
| 卷 30, 编号 11 (2024) |
A Snapshot of Selenium-enclosed Nanoparticles for the Management of Cancer |
(Eng)
|
|
Deshmukh R., Singh R., Sharma S., Mishra A., Harwansh R.
|
| 卷 30, 编号 5 (2024) |
A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma |
(Eng)
|
|
Zhou X., Tan F., Zhang S., Wang A., Zhang T.
|
| 卷 30, 编号 42 (2024) |
Acknowledgements to Reviewers |
(Eng)
|
|
|
| 卷 30, 编号 36 (2024) |
Active Ingredients and Mechanism of Gegen Qinlian Decoction in the Treatment of Diabetic Cardiomyopathy: A Network Pharmacology Study |
(Eng)
|
|
Wang M., Liang Y., Qin Y., Ma R., Yu H., Wang W., Zhang X.
|
| 卷 30, 编号 35 (2024) |
Advancements Beyond Limb Loss: Exploring the Intersection of AI and BCI in Prosthetic Evaluation |
(Eng)
|
|
Islam M., Vashishat A., Kumar M.
|
| 卷 30, 编号 37 (2024) |
Advancements in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Breast Cancer Therapy |
(Eng)
|
|
Marwah H., Dewangan H.
|
| 卷 30, 编号 35 (2024) |
Advancements in the Transdermal Drug Delivery Systems Utilizing Microemulsion-based Gels |
(Eng)
|
|
Song Y., Chen W., Yin Y., Li J., Wang M., Liu Y., Ren X.
|
| 卷 30, 编号 11 (2024) |
Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells |
(Eng)
|
|
Rajput S., Malviya R., Uniyal P.
|
| 卷 30, 编号 21 (2024) |
Advancing Novel Strategies against Post-surgical Tendon Adhesion Bands, Exploring New Frontiers |
(Eng)
|
|
Alaei M., Abdulhasan D., Barjasteh A., Al-Asady A., Latifi H., Vahedi E., Avan A., Khazaei M., Ryzhikov M., Hassanian S.
|
| 卷 30, 编号 31 (2024) |
An Insight into Biodegradable Polymers and their Biomedical Applications for Wound Healing |
(Eng)
|
|
Halder T., Barot H., Kumar B., Kaushik V., Patel H., Bhut H., Saha B., Poddar S., Acharya N.
|
| 卷 30, 编号 40 (2024) |
An Overview of the Analytical Methods for Products Based on Clindamycin and Eco-efficiency Perspectives |
(Eng)
|
|
Lustosa I., Kogawa A.
|
| 卷 30, 编号 36 (2024) |
An Update on Colistin in Clinical Healthcare Unit in the Kingdom of Saudi Arabia: A Narrative Review |
(Eng)
|
|
Faidah H.
|
| 卷 30, 编号 39 (2024) |
Anti-cancer Drug Targeting using Stimuli Sensitive Mesoporous Silica Nanoparticle in Colorectal Cancer |
(Eng)
|
|
Mainuddin ., Kumar A., Sharma A., Sharma N.
|
| 卷 30, 编号 7 (2024) |
Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices |
(Eng)
|
|
Spartalis M., Kontogiannis C., Spartalis E., Iliopoulos D., Siasos G.
|
| 卷 30, 编号 4 (2024) |
Applications of Pyrrole and Pyridine-based Heterocycles in Cancer Diagnosis and Treatment |
(Eng)
|
|
Tyagi R., Yadav K., Srivastava N., Sagar R.
|
| 卷 30, 编号 3 (2024) |
Artesunate Inhibits the Growth of Insulinoma Cells via SLC7A11/ GPX4-mediated Ferroptosis |
(Eng)
|
|
Chen F., Lu J., Zheng B., Yi N., Xie C., Chen F., Wei D., Jiang H., Qin S.
|
| 卷 30, 编号 6 (2024) |
Artificial Intelligence Technologies used for the Assessment of Pharmaceutical Excipients |
(Eng)
|
|
Kumar A., Gupta G., Raikwar S.
|
| 卷 30, 编号 39 (2024) |
Assessing TGF-β Prognostic Model Predictions for Chemotherapy Response and Oncogenic Role of FKBP1A in Liver Cancer |
(Eng)
|
|
Chen W., Que Q., Zhong R., Lin Z., Yi Q., Wang Q.
|
| 卷 30, 编号 15 (2024) |
Association of Parity with the Risks of Gestational Diabetes and Macrosomia: A Retrospective Cohort Study in Nanjing, China |
(Eng)
|
|
Geng S., Wang J., Geng Z., Wen J.
|
| 卷 30, 编号 21 (2024) |
Ayurvedic and Chinese Herbs against Coronaviruses |
(Eng)
|
|
Gasmi A., Kanwal S., Oliinyk P., Lysiuk R., Shanaida M., Gasmi Benahmed A., Dushmantha W., Arshad M., Kernychna I., Lenchyk L., Upyr T., Shanaida V., Bjørklund G.
|
| 卷 30, 编号 19 (2024) |
Bear Bile Powder Improves Ulcerative Colitis by Protecting the Intestinal Mechanical Barrier and Regulating Intestinal Flora |
(Eng)
|
|
Liu Z., Ye X., Wu C., Wei D.
|
| 卷 30, 编号 36 (2024) |
Bioactive Compounds in Citrus Species with Potential for the Treatment of Chronic Venous Disease: A Review |
(Eng)
|
|
Almeida Silva V., de Freitas Pereira E., Ferreira J., Magno Teixeira A., Borges R., da Silva L.
|
| 卷 30, 编号 41 (2024) |
Biocompatible Electrospun Hydrogel Fibers for Advanced Wound Healing Therapies |
(Eng)
|
|
Yadav P., Gupta M., Singh S., Parashar P.
|
| 卷 30, 编号 35 (2024) |
Biological and Photocatalytic Activities of Silver Nanoparticles Synthesized from the Leaf Extract of Euphorbia royleana Boiss |
(Eng)
|
|
Begum H., Yaseen S., Zada A., Musa M., Khan A., Sheheryar ., Alrefaei A., Almutairi M., Ali S., Azmat R., Hamayun M.
|
| 卷 30, 编号 22 (2024) |
Biopharmaceuticals: Challenges and Opportunities in Formulation and Delivery |
(Eng)
|
|
Kamal R., Paul P., Singh A., Awasthi A.
|
| 卷 30, 编号 1 (2024) |
Breast Cancer-related Lymphedema: Recent Updates on Clinical Efficacy of Therapies and Bioengineering Approaches for a Personalized Therapy |
(Eng)
|
|
Zhang X., Beeraka N., Sinelnikov M., Glazachev O., Ternovoy K., Lu P., Isaeva A., Cao Y., Zhang J., Nezhad A., Plotnikova M., Chen K.
|
| 卷 30, 编号 2 (2024) |
Capsicum annuum Oleoresin Nanoemulgel - Design Characterization and In vitro Investigation of Anticancer and Antimicrobial Activities |
(Eng)
|
|
Eid A., Natsheh H., Issa L., Zoabi M., Amer M., Mahamid E., Mousa A.
|
| 卷 30, 编号 2 (2024) |
Carbon Nanotubes for Targeted Therapy: Safety, Efficacy, Feasibility and Regulatory Aspects |
(Eng)
|
|
Gupta B., Sharma P., Malviya R.
|
| 卷 30, 编号 15 (2024) |
CASC19: An Oncogenic Long Non-coding RNA in Different Cancers |
(Eng)
|
|
Wu Y., Mou J., Zhou G., Yuan C.
|
| 卷 30, 编号 16 (2024) |
Celastrol Elicits Antitumor Effects through Inducing Immunogenic Cell Death and Downregulating PD-L1 in ccRCC |
(Eng)
|
|
Li H., Zhu N., Wu J., Shi Y., Gu J., Qin L.
|
| 卷 30, 编号 13 (2024) |
Cellular and Mitochondrial Pathways Contribute to SGLT2 Inhibitors-mediated Tissue Protection: Experimental and Clinical Data |
(Eng)
|
|
Sanz R., Menéndez S., Inserra F., Ferder L., Manucha W.
|
| 卷 30, 编号 10 (2024) |
Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era |
(Eng)
|
|
Giordano A., Gallicchio R., Milella M., Storto R., Nardelli A., Pellegrino T., Nappi A., Di Cosola M., Storto G.
|
| 卷 30, 编号 33 (2024) |
Chemoprophylaxis Effect of EGCG on the Recurrence of Colorectal Cancer: A Systematic Review and Meta-Analysis |
(Eng)
|
|
He B., Kang S., Su R., Wu S., Liu X., Liu M., Chen S.
|
| 卷 30, 编号 10 (2024) |
Cholesteryl Ester Transfer Protein (CETP) Variations in Relation to Lipid Profiles and Cardiovascular Diseases: An Update |
(Eng)
|
|
Dabravolski S., Orekhov N., Melnichenko A., Sukhorukov V., Popov M., Orekhov A.
|
| 卷 30, 编号 36 (2024) |
Cisplatin-based Liposomal Nanocarriers for Drug Delivery in Lung Cancer Therapy: Recent Progress and Future Outlooks |
(Eng)
|
|
Mohammad-Jafari K., Naghib S., Mozafari M.
|
| 卷 30, 编号 18 (2024) |
Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights |
(Eng)
|
|
Soleimani A., Saeedi N., Al-Asady A., Nazari E., Hanaie R., Khazaei M., Ghorbani E., Akbarzade H., Ryzhikov M., Avan A., Mehr S.
|
| 卷 30, 编号 12 (2024) |
Compounds based on Adamantyl-substituted Amino Acids and Peptides as Potential Antiviral Drugs Acting as Viroporin Inhibitors |
(Eng)
|
|
Garaev T., Grebennikova T., Lebedeva V., Avdeeva V., Larichev V.
|
| 卷 30, 编号 20 (2024) |
Comprehensive Overview of Innovative Strategies in Preventing Renal Ischemia-reperfusion Injury: Insights from Bibliometric and In silico Analyses |
(Eng)
|
|
Rysmakhanov M., Zare A., Smagulov A., Abenova N., Mussin N., Sultangereyev Y., Zhakiyev B., Kuttymuratov G., Haberal M., Jafari N., Baneshi H., Bakhshalizadeh S., Mahdipour M., Rahmanifar F., Tamadon A.
|
| 卷 30, 编号 30 (2024) |
Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders |
(Eng)
|
|
Nayak N., Mukherjee T., Pattnaik A.
|
| 卷 30, 编号 20 (2024) |
Computational Screening of Some Phytochemicals to Identify Best Modulators for Ligand Binding Domain of Estrogen Receptor Alpha |
(Eng)
|
|
Alagarsamy V., Sundar P., Solomon V., Murugesan S., Muzaffar-Ur-Rehman M., Kulkarni V., Sulthana M., Narendhar B., Sabarees G.
|
| 卷 30, 编号 25 (2024) |
Construction, Features and Regulatory Aspects of Organ-chip for Drug Delivery Applications: Advances and Prospective |
(Eng)
|
|
Gupta B., Malviya R., Srivastava S., Ahmad I., Rab S., Uniyal P.
|
| 卷 30, 编号 19 (2024) |
Construction of GPC3-modified Lipopolymer SiRNA Delivery System |
(Eng)
|
|
Sun D., Li X., Liu Y., Quan J., Jin G.
|
| 卷 30, 编号 40 (2024) |
Correlation between the Atherogenic Index of Plasma and Progression of Non-target Lesion Vascular Disease Following Percutaneous Coronary Intervention using Drug-eluting Stents |
(Eng)
|
|
Hou T., Wang F., Hao C., Zhang C., Ning M., Chen Y., Wang K., Liu Y.
|
| 卷 30, 编号 17 (2024) |
Corrigendum to: Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophorae Decoction |
(Eng)
|
|
Yuan Y., Wu H., Shuai B., Liu C., Zhu F., Gao F., Wei C., Fan H.
|
| 卷 30, 编号 15 (2024) |
Corrigendum: N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation |
(Eng)
|
|
Davood A., EbrahimiNassimi Y., Sardari S., Farahani Y.
|
| 卷 30, 编号 41 (2024) |
Cpd861 Targeting BCL2 to Alleviate Hepatic Fibrosis: Network Pharmacology, Mendelian Randomization, and Molecular Docking Mechanisms |
(Eng)
|
|
Lyu Y., Liang X., Gao S., Li J., Li J., Zhang S., Yin C., Chi C.
|
| 卷 30, 编号 15 (2024) |
CRISPR and Gene Editing: A Game-changer in Drug Development |
(Eng)
|
|
Verma A., Sharma T., Awasthi A.
|
| 卷 30, 编号 23 (2024) |
CRISPR/Cas9 Technology: A Novel Approach to Obesity Research |
(Eng)
|
|
Khademi Z., Mahmoudi Z., Sukhorukov V., Jamialahmadi T., Sahebkar A.
|
| 卷 30, 编号 10 (2024) |
Cumulative Exposure to Oxidized Low-density Lipoprotein is a Potential Predictor for Prognosis in Acute Ischemic Stroke: A Cohort Study |
(Eng)
|
|
Cheng K., Chen X., Luo Y., Sun W., Yang X., Huang S., Wang Y., Wu D.
|
| 卷 30, 编号 23 (2024) |
Curcumin in Cancer Prevention: Insights from Clinical Trials and Strategies to Enhance Bioavailability |
(Eng)
|
|
Alam S., Lee J., Sahebkar A.
|
| 卷 30, 编号 10 (2024) |
Current and Emerging Pharmacological Therapies for Cushing's Disease |
(Eng)
|
|
Divaris E., Kostopoulos G., Efstathiadou Z.
|
| 卷 30, 编号 29 (2024) |
Current Insights in Murine Models for Breast Cancer: Present, Past and Future |
(Eng)
|
|
Jain M., Goel A.
|
| 卷 30, 编号 4 (2024) |
Deciphering Multi-target Pharmacological Mechanism of Cucurbita pepo Seeds against Kidney Stones: Network Pharmacology and Molecular Docking Approach |
(Eng)
|
|
Shahzadi A., Ashfaq U., Khurshid M., Nisar M., Syed A., Bahkali A.
|
| 卷 30, 编号 12 (2024) |
Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids |
(Eng)
|
|
Vettorato E., Fiordelisi M., Ferro S., Zanin D., Franceschinis E., Marzaro G., Realdon N.
|
| 卷 30, 编号 34 (2024) |
Dental Caries: Unveiling the State-of-the-art Insights and Crafting Hypotheses for Oral Health |
(Eng)
|
|
Kaur P., Vyas M., Sharma S.
|
| 卷 30, 编号 30 (2024) |
Design and Development of Ophthalmic Liposomes from the QbD Perspective |
(Eng)
|
|
Pawar K., Shaikh K.
|
| 卷 30, 编号 15 (2024) |
Design of Nanodrug Delivery Systems for Tumor Bone Metastasis |
(Eng)
|
|
Zhai X., Peng S., Zhai C., Wang S., Xie M., Guo S., Bai J.
|
| 卷 30, 编号 27 (2024) |
Design, Synthesis and Evaluation of a Novel Teoptinib Derivative as an Effective Anti-hepatocellular Carcinoma Agent |
(Eng)
|
|
Yu H., Zhang X., Li J., Wang K., Yin C., Li X., Li L., Shao G., Jin S.
|
| 卷 30, 编号 24 (2024) |
Development and Evaluation of PEG-gelatin-based Microparticles to Enhance the Oral Delivery of Insulin |
(Eng)
|
|
Buxaderas E., Akpa P., Hanifah A., Oseni O., Kenechukwu F., Mumuni M., Diaz D., Alfa J., Ben A.
|
| 卷 30, 编号 12 (2024) |
Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients |
(Eng)
|
|
JIang W., Dong J., Zhang W., Huang Z., Guo T., Zhang K., Jiang X., Du T.
|
| 卷 30, 编号 22 (2024) |
Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review |
(Eng)
|
|
Sharma K., Mohsin M., Mittal P., Ali Z., Fatma N., Upadhyay P., Gupta R., Verma A., Kumar G.
|
| 卷 30, 编号 1 (2024) |
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics |
(Eng)
|
|
Sokolov D., Sharda N., Banerjee A., Denisenko K., Basalious E., Shukla H., Waddell J., Hamdy N., Banerjee A.
|
| 卷 30, 编号 25 (2024) |
Discovery of an EP300 Inhibitor using Structure-based Virtual Screening and Bioactivity Evaluation |
(Eng)
|
|
Pan D., Huang Y., Jiang D., Zhang Y., Wu M., Han M., Jin X.
|
| 卷 30, 编号 33 (2024) |
Diuretic Combination Therapy in Acute Heart Failure: An Updated Review |
(Eng)
|
|
Villaschi A., Pellegrino M., Condorelli G., Chiarito M.
|
| 卷 30, 编号 31 (2024) |
Doxorubicin-induced Immunogenic Cell Death Impairs Tumor Progression and Distant Metastasis in a 4T1 Breast Cancer Tumor Model |
(Eng)
|
|
Cardador C., de Castro T., de Castro R., Bocca A., Camargo L., Pacheco T., Muehlmann L., Longo J.
|
| 卷 30, 编号 26 (2024) |
Drug Release and Stability Study of Innovated Losartan Potassium and Rosuvastatin Calcium Fixed-dose Combination Tablet |
(Eng)
|
|
Zeb M., Khan S., Ataya F., Batiha G., Kashtoh H., Khan A., Al-Harrasi A.
|
| 卷 30, 编号 27 (2024) |
Effect of Ozone Therapy on Diabetes-related Foot Ulcer Outcomes: A Systematic Review and Meta-analysis |
(Eng)
|
|
Izadi M., Jafari-Oori M., Eftekhari Z., Jafari N., Maybodi M., Heydari S., Vahedian-Azimi A., Atkin S., Jamialahmadi T., Sahebkar A.
|
| 卷 30, 编号 19 (2024) |
Effect of Raltitrexed on ECA109 Cellular Radiosensitivity and its Mechanism in Esophageal Cancer |
(Eng)
|
|
Xu L., Wu C., Wang Y., Zhou J.
|
| 卷 30, 编号 20 (2024) |
Effect of Statins on Serum Levels of TNF-alpha and Interleukin-6 in Patients with Kidney Disease: A Meta-analysis of Randomized Clinical Trials |
(Eng)
|
|
Razi B., Aslani S., Imani D., Salehiyeh S., Fasihi M., Reiner ., Sahebkar A.
|
| 卷 30, 编号 15 (2024) |
Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis |
(Eng)
|
|
Yang S., Xu Y., Zhang Y., Li D., Li X.
|
| 卷 30, 编号 39 (2024) |
Effects of CYP3A5 Genetic Polymorphisms on the Weight-adjusted through Concentration of Sirolimus in Renal Transplant Recipients: A Systematic Review and Meta-analysis |
(Eng)
|
|
Park Y., Park J., Yee J., Gwak H.
|
| 卷 30, 编号 7 (2024) |
Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review |
(Eng)
|
|
Deftereos S., Vavougios G., Bakirtzis C., Hadjigeorgiou G., Grigoriadis N.
|
| 卷 30, 编号 29 (2024) |
Effects of Sex Differences and Combined Use of Clozapine on Initial Dosage Optimization of Valproic Acid in Patients with Bipolar Disorder |
(Eng)
|
|
Shen W., Hu K., Shi H., Jiang L., Zhang Y., He S., Zhang C., Chen X., Wang D.
|
| 卷 30, 编号 33 (2024) |
Efficacy and Mechanism of Core Traditional Chinese Medicines for Treating Malignant Lymphoma based on Efficacy Studies: A Study Supported by Network Pharmacology and Molecular Docking |
(Eng)
|
|
Jin J., Ren S., Han B., Zhang W., Xu H., Yang J., Liu J.
|
| 卷 30, 编号 8 (2024) |
Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril? |
(Eng)
|
|
Karcioglu O., Akman C., Atnis I.
|
| 卷 30, 编号 6 (2024) |
Efficacy of Methylphenidate for Internet Gaming Disorder and Internet Addiction in Patients with Attention-Deficit/Hyperactivity Disorder |
(Eng)
|
|
Salvati A., Sesso G., Lenzi F., Masi G., Berloffa S.
|
| 卷 30, 编号 29 (2024) |
Elemene Injection Overcomes Paclitaxel Resistance in Breast Cancer through AR/RUNX1 Signal: Network Pharmacology and Experimental Validation |
(Eng)
|
|
Gu X., Xu L., Fu Y., Fan S., Huang T., Yu J., Chen J., Sui X., Xie X.
|
| 卷 30, 编号 16 (2024) |
Elucidation of the Molecular Mechanism of Compound Danshen Dripping Pills against Angina Pectoris based on Network Pharmacology and Molecular Docking |
(Eng)
|
|
Tian X., Yin S., Liu Z., Cao J., Liu X., Qiu Q.
|
| 卷 30, 编号 35 (2024) |
Encapsulating Rhodamine 6G in Oxidized Sodium Alginate Polymeric Hydrogel for Photodynamically Inactivating Cancer Cells |
(Eng)
|
|
Pallavi P., Girigoswami K., Gowtham P., Harini K., Thirumalai A., Girigoswami A.
|
| 卷 30, 编号 21 (2024) |
Endothelial-specific Enhancer as a Cis Element of PLAUR Regulation by TNF-alpha, IL-1beta, and VEGF |
(Eng)
|
|
Penkov D., Beloglazova I., Parfyonova Y.
|
| 卷 30, 编号 14 (2024) |
Enhancing the Antiproliferative Activity of Perillyl Alcohol against Glioblastoma Cell Lines through Synergistic Formulation with Natural Oils |
(Eng)
|
|
Alharbi W., Alshehri A., Ahmed T., Md. S., Almehmady A., Alshabibi M., Altamimi R., El-Say K.
|
| 卷 30, 编号 18 (2024) |
Evaluating the Imperative Role of Pre- and Post-eCTD Standards in Dossier Validation: An Inevitable Outlook |
(Eng)
|
|
Patil N., Ranjan A., Narang R., Singh A.
|
| 卷 30, 编号 37 (2024) |
Evaluation of the Hypoglycemic and Hypolipidemic Potential of Extract Fraction of Quercus baloot Griff Seeds in Alloxan-induced Diabetic Mice |
(Eng)
|
|
Musa M., Rahman S., Ali N., Hamayun M., Alrefai A., Almutairi M., Azmat R., Ali S., Hussain S., Gul Jan F., Jan G., Irfan M.
|
| 卷 30, 编号 22 (2024) |
Examining the Mechanism of Treatment for Primary Dysmenorrhea with Wenjing Huoxue Decoction based on Transcriptomics, Metabolomics, and Network Pharmacology |
(Eng)
|
|
Fan W., Wang D., Yan L., Yuan Z.
|
| 卷 30, 编号 40 (2024) |
Experiments Validated the Development of Zebrafish Embryos and Toxicological Mechanism of Borneols in Perinatal Period |
(Eng)
|
|
Xie Q., Lu D., Ma R., Zeng X., Guo J.
|
| 卷 30, 编号 37 (2024) |
Exploration of Pharmacological Mechanism of Cinnamomum tamala Essential Oil in Treating Inflammation based on Network Pharmacology, Molecular Modelling, and Experimental Validation |
(Eng)
|
|
Mohanty D., Padhee S., Jena S., Sahoo A., Panda P., Nayak S., Ray A.
|
| 卷 30, 编号 14 (2024) |
Exploration of the Mechanisms Underlying Yu's Enema Formula in Treating Ulcerative Colitis by Blocking the RhoA/ROCK Pathway based on Network Pharmacology, High-performance Liquid Chromatography Analysis, and Experimental Verification |
(Eng)
|
|
Liu B., Zhang J., Wang X., Ye W., Yao J.
|
| 卷 30, 编号 25 (2024) |
Exploration of the Shared Gene Signatures and Molecular Mechanisms between Chronic Bronchitis and Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis: Evidence from Transcriptome Data |
(Eng)
|
|
Cai X., Li Y., Liu Q., Gao X., Li J.
|
| 卷 30, 编号 22 (2024) |
Exploring Innovative Approaches in Type-2 Diabetes Management: A Comprehensive Review on Nano-carriers and Transdermal Drug Delivery |
(Eng)
|
|
Chauhan N., Kumar M., Kumar K., Chopra S., Bhatia A.
|
| 1 - 100 的 257 信息 |
1 2 3 > >> |
